Blood glucose control in the perioperative period

Minerva Anestesiologica

Volumn 78, Issue 5, 2012, Pages 574-595

  Kadoi, Y ^a  

^a GUNMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Anesthetics; Blood glucose; Hypoglycemia; Perioperative care

Indexed keywords

ANESTHETIC AGENT; CLONIDINE; DEXMEDETOMIDINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENFLURANE; ETOMIDATE; GLUCOSE; GLUCOSE TRANSPORTER 4; GROWTH HORMONE; HALOTHANE; HARTMANN SOLUTION; HEMOGLOBIN A1C; HYDROCORTISONE; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; ISOFLURANE; MIDAZOLAM; OPIATE; POTASSIUM; PROPOFOL; TUMOR NECROSIS FACTOR ALPHA;

ANESTHESIA; BLOOD GLUCOSE MONITORING; CARDIAC PATIENT; CONTINUOUS INFUSION; CORONARY ARTERY BYPASS GRAFT; DIABETIC PATIENT; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; GLUCOSE HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOTENSION; INSULIN INFUSION; INSULIN RESISTANCE; INSULIN TREATMENT; INTENSIVE CARE UNIT; INTRAOPERATIVE PERIOD; MORBIDITY; MORTALITY; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGIONAL ANESTHESIA; REVIEW;

ANESTHESIA, CONDUCTION; ANESTHETICS; BLOOD GLUCOSE; CLINICAL PROTOCOLS; DIABETES MELLITUS; HUMANS; HYPERGLYCEMIA; HYPNOTICS AND SEDATIVES; INTENSIVE CARE; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS;

EID: 84860281500     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (136)

1. Kadoi Y. Perioperative considerations in diabetic patients. Curr Diabetes Rev 2010;6:236-46.
2. Lipshutz AK, Gropper MA. Perioperative glycemic control: an evidence-based review. Anesthesiology 2009;110:408-21.
3. Akhtar S, Barash PG, Inzucchi SE. Scientific principles and clinical implications of perioperative glucose regulation and control. Anesth Analg 2010;110:478-97.
4. Fahy BG, Sheehy AM, Coursin DB. Glucose control in the intensive care unit. Crit Care Med 2009;37:1769-76.
5. Kadoi Y. Anesthetic considerations in diabetic patients. Part I: preoperative considerations of patients with diabetes mellitus. J Anesth 2010;24:739-47.
6. Kadoi Y. Anesthetic considerations in diabetic patients. Part II: intraoperative and postoperative management of patients with diabetes mellitus. J Anesth 2010;24:748-56.
7. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckz F, Schetz M et al. Intensive insulin therapy in critically ill patients. New Engl J Med 2001;345:1359-67.
8. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449-61.
9. Preiser JC, Devos P, Ruiz-Santana S, Mélot C, Annane D, Groeneveld J et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 2009;35:1738-48.
10. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N et al. German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-39.
11. Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, O'Brien PC et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med 2007;146:233-43.
12. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283-97.
13. Lazar HL, McDonnell M, Chipkin SR, Furnary AP, Engelman RM, Sadhu AR et al. Society of Thoracic Surgeons Blood Glucose Guideline Task Force. The Society of Thoracic Surgeons practice guideline series: Blood glucose management during adult cardiac surgery. Ann Thorac Surg 2009;87:663-9.
14. Landoni G, Biondi-Zoccai GG, Zangrillo A, Bignami E, D'Avolio S, Marchetti C et al. Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth 2007;21:502-11.
15. Donatelli F, Vavassori A, Bonfanti S, Parrella P, Lorini L, Fumagalli R et al. Epidural anesthesia and analgesia decrease the postoperative incidence of insulin resistance in preoperative insulin-resistant subjects only. Anesth Analg 2007;104:1587-93.
16. Lattermann R, Carli F, Wykes L, Schricker T. Epidural blockade modifies perioperative glucose production without affecting protein catabolism. Anesthesiology 2002;97:374-81.
17. Yamasaki K, Inagaki Y, Mochida S, Funaki K, Takahashi S, Sakamoto S. Effect of intraoperative acetated Ringer's solution with 1% glucose on glucose and protein metabolism. J Anesth 2010;24:426-31.
18. Mikura M, Yamaoka I, Doi M, Kawano Y, Nakayama M, Nakao R et al. Glucose infusion suppresses surgery-induced muscle protein breakdown by inhibiting ubiquitin-proteasome pathway in rats. Anesthesiology 2009;110:81-8.
19. Ljungqvist O, Thorell A, Gutniak M, Häggmark T, Efendic S. Glucose infusion instead of preoperative fasting reduces postoperative insulin resistance. J Am Coll Surg 1994;178:329-36.
20. Lauruschkat AH, Arnrich B, Albert AA, Walter JA, Amann B, Rosendahl UP et al. Prevalence and risks of undiagnosed diabetes mellitus in patients undergoing coronary artery bypass grafting. Circulation 2005;112:2397-402.
21. McGirt MJ, Woodworth GF, Brooke BS, Coon AL, Jain S, Buck D et al. Hyperglycemia independently increases the risk of perioperative stroke, myocardial infarction, and death after carotid endarterectomy. Neurosurgery 2006;58:1066-73.
22. Dronge AS, Perkal MF, Kancir S, Concato J, Aslan M, Rosenthal RA. Long-term glycemic control and postoperative infectious complications. Arch Surg 2006;141:375-80.
23. Rovlias A, Kotsou S. The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery 2000;46:335-42.
24. Yendamuri S, Fulda GJ, Tinkoff GH. Admission hyperglycemia as a prognostic indicator in trauma. J Trauma 2003;55:33-8.
25. Laird AM, Miller PR, Kilgo PD, Meredith JW, Chang MC. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma 2004;56:1058-62.
26. Sung J, Bochicchio GV, Joshi M, Bochicchio K, Tracy K, Scalea TM. Admission hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma 2005;59:80-3.
27. Safavi M, Honarmand A. The impact of admission hyperglycemia or hypoalbuminemia on need ventilator, time ventilated, mortality, and morbidity in critically ill trauma patients. Ulus Travma Acil Cerrahi Derg 2009;15:120-9.
28. Freire AX, Bridges L, Umpierrez GE, Kuhl D, Kitabchi AE. Admission hyperglycemia and other risk factors as predictors of hospital mortality in a medical ICU population. Chest 2005;128:3109-16.
29. Guvener M, Pasaoglu I, Demircin M, Oc M. Perioperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. Endocr J 2002;49:531-7.
30. Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003;125:1007-21.
31. Bagry HS, Raghavendran S, Carli F. Metabolic syndrome and insulin resistance: perioperative considerations. Anesthesiology 2008;108:506-23.
32. Weekers F, Giulietti AP, Michalaki M, Coopmans W, Van Herck E, Mathieu C et al. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology 2003;144:5329-38.
33. Turina M, Fry DE, Polk HC Jr. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med 2005;33:1624-33.
34. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002;106:2067-72.
35. Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabet Med 2002;19:527-34.
36. Thorell A, Efendic S, Gutniak M, Häggmark T, Ljungqvist O. Insulin resistance after abdominal surgery. Br J Surg 1994;81:59-63.
37. Thorell A, Hirshman MF, Nygren J, Jorfeldt L, Wojtaszewski JF, Dufresne SD et al. Exercise and insulin cause GLUT-4 translocation in human skeletal muscle. Am J Physiol 1999;277:E733-41.
38. Thorell A, Nygren J, Ljungqvist O. Insulin resistance: a marker of surgical stress. Curr Opin Clin Nutr Metab Care 1999;2:69-78.
39. Clarke RS. The hyperglycaemic response to different types of surgery and anaesthesia. Br J Anaesth 1970;42:45-53.
40. Thorell A, Nygren J, Essén P, Gutniak M, Loftenius A, Andersson B et al. The metabolic response to cholecystectomy: insulin resistance after open compared with laparoscopic operation. Eur J Surg 1996;162:187-91.
41. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003;31:359-66.
42. Langouche L, Vanhorebeek I, Vlasselaers D, Vander Perre S, Wouters PJ, Skogstrand K, et al. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 2005;115:2277-86.
43. Fragen RJ, Shanks CA, Molteni A, Avram MJ. Effects of etomidate on hormonal responses to surgical stress. Anesthesiology 1984;61:652-6.
44. Desborough JP, Hall GM, Hart GR, Burrin JM. Midazolam modifies pancreatic and anterior pituitary hormone secretion during upper abdominal surgery. Br J Anesth 1991;67:390-6.
45. Gaumann D, Tassonyi E, Rivest RW, Fathi M, Reverdin AF. Cardiovascular and endocrine effects of clonidine premedication in neurosurgical patients. Can J Anesth 1991;38:837-43.
46. Metz SA, Halter JB, Robertson RP. Induction of defective insulin secretion and impaired glucose tolerance by clonidine. Selective stimulation of metabolic alpha-adrenergic pathway. Diabetes 1978;27:554-62.
47. Lyons FM, Bew S, Sheeran P, Hall GM. Effects of clonidine on the pituitary hormonal response to pelvic surgery. Br J Anesth 1997;78:134-7.
48. Belhoula M, Ciebiera JP, De La Chapelle A, Boisseau N, Coeurveille D, Raucoules-Aime M. Clonidine premedication improves metabolic control in type 2 diabetic patients during ophthalmic surgery. Br J Anesth 2003;90:434-9.
49. Venn RM, Bryant A, Hall GM, Grounds RM. Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in postoperative patients needing sedation in the intensive care unit. Br J Anesth 2001;86:650-6.
50. Hall GM, Lacoumenta S, Hart GR, Burrin JM. Site of action of fentanyl in inhibiting the pituitary-adrenal response to surgery in man. Br J Anesth 1990;65:251-3.
51. Desborough JP, Jones PM, Persaud SJ, Landon MJ, Howell SL. Isoflurane inhibits insulin secretion from isolated rat pancreatic islets of Langerhans. Br J Anesth 1993;71:873-6.
52. Gingerich R, Wright PH, Paradise RR. Inhibition by halothane of glucose-stimulated insulin secretion in isolated pieces of rat pancreas. Anesthesiology 1974;40:449-52.
53. Diltoer M, Camu F. Glucose homeostasis and insulin secretion during isoflurane anesthesia. Anesthesiology 1988;68:880-6.
54. David JS, Tavernier B, Amour J, Vivien B, Coriat P, Riou B. Myocardial effects of halothane and sevoflurane in diabetic rats. Anesthesiology 2004;100:1179-87.
55. Wicklmyr M, Rett K, Dietz G, Mehnert H. Comparison of metabolic clearance rates of MCT/LCT and LCT emulsions in diabetics. J Parenteral Enteral Nutr 1988;12:68-71.
56. Leal N, Calvo R, Agrad FZ, Lukas JC, de la Fuente L, Suarez E. Altered dose-to-effect of propofol due to pharmacokinetics in rats with experimental diabetes mellitus. J Pharm Pharmacol 2005;57:317-25.
57. Hall GM. The anesthetic modification of the endocrine and metabolic response to surgery. Ann R Coll Surg Engl 1985;67:25-9.
58. Mistraletti G, De La Cuadra-Fontaine JC, Asenjo FJ, Donatelli F, Wykes L, Schricker T et al. Comparison of analgesic methods for total knee arthroplasty: metabolic effect of exogenous glucose. Reg Anesth Pain Med 2006;31:260-9.
59. Halter JB, Pflug AE. Effect of sympathetic blockade by spinal anesthesia on pancreatic islet function in man. Am J Physiol 1980;239:E150-55.
60. Nakao K, Miyata M. The influence of phentolamine, an adrenergic blocking agent, on insulin secretion during surgery. Eur J Clin Invest 1977;7:41-5.
61. Noordzij PG, Boersma E, Schreiner F, Kertai MD, Feringa HH, Dunkelgrun M et al. Increased preoperative glucose levels are associated with perioperative mortality in patients undergoing noncardiac, nonvascular surgery. Eur J Endocrinol 2007;156:137-42.
62. Lazar HL, Chipkin S, Philippides G, Bao Y, Apstein C. Glucose-insulin-potassium solutions improve outcomes in diabetics who have coronary artery operations. Ann Thorac Surg 2000;70:145-50.
63. Rao V, Christakis GT, Weisel RD, Ivanov J, Borger MA, Cohen G. The insulin cardioplegia trial: myocardial protection for urgent coronary artery bypass grafting. J Thorac Cardiovasc Surg 2002;123:928-35.
64. Hynninen M, Borger MA, Rao V, Weisel RD, Christakis GT, Carroll JA et al. The effect of insulin cardioplegia on atrial fibrillation after high-risk coronary bypass surgery: a double-blinded, randomized, controlled trial. Anesth Analg 2001;92:810-6.
65. Lazar HL, Chipkin S, Philippides G, Bao Y, Apstein C. Glucose-insulin-potassium solutions improve outcomes in diabetics who have coronary artery operations. Ann Thorac Surg 2000;70:145-50.
66. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999;67:352-60.
67. Puskas F, Grocott HP, White WD, Mathew JP, Newman MF, Bar-Yosef S. Intraoperative hyperglycemia and cognitive decline after CABG. Ann Thorac Surg 2007;84:1467-73.
68. Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, O'Brien PC et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med 2007;146:233-43.
69. Chaney MA, Nikolov MP, Blakeman BP, Bakhos M. Attempting to maintain normoglycemia during cardiopulmonary bypass with insulin may initiate postoperative hypoglycemia. Anesth Analg 1999;89:1091-5.
70. Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 1997;63:356-61.
71. Schmeltz LR, DeSantis AJ, Thiyagarajan V, Schmidt K, O'Shea-Mahler E, Johnson D et al. Reduction of surgical mortality and morbidity in diabetic patients undergoing cardiac surgery with a combined intravenous and subcutaneous insulin glucose management strategy. Diabetes Care 2007;30:823-8.
72. D'Alessandro C, Leprince P, Golmard JL, Ouattara A, Aubert S, Pavie A et al. Strict glycemic control reduces Euro- SCORE expected mortality in diabetic patients undergoing myocardial revascularization. J Thorac Cardiovasc Surg 2007;134:29-37.
73. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004;109:1497-502.
74. Ouattara A, Lecomte P, Le Manach Y, Landi M, Jacqueminet S, Platonov I, et al. Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anesthesiology 2005;103:687-94.
75. Doenst T, Wijeysundera D, Karkouti K, Zechner C, Maganti M, Rao V et al. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 2005;130:1144.
76. Estrada CA, Young JA, Nifong LW, Chitwood WR Jr. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg 2003;75:1392-9.
77. Hill SE, van Wermeskerken GK, Lardenoye JW, Phillips- Bute B, Smith PK, Reves JG et al. Intraoperative physiologic variables and outcome in cardiac surgery: Part I. In-hospital mortality. Ann Thorac Surg 2000;69:1070-5.
78. Koskenkari JK, Kaukoranta PK, Kiviluoma KT, Raatikainen MJ, Ohtonen PP, Ala-Kokko TI. Metabolic and hemodynamic effects of high-dose insulin treatment in aortic valve and coronary surgery. Ann Thorac Surg 2005;80:511-7.
79. Rao V, Christakis GT, Weisel RD, Ivanov J, Borger MA, Cohen G. The insulin cardioplegia trial: myocardial protection for urgent coronary artery bypass grafting. J Thorac Cardiovasc Surg 2002;123:928-35.
80. Butterworth J, Wagenknecht LE, Legault C, Zaccaro DJ, Kon ND, Hammon JW Jr et al. Attempted control of hyperglycemia during cardiopulmonary bypass fails to improve neurologic or neurobehavioral outcomes in patients without diabetes mellitus undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2005;130:1319.
81. Pasternak JJ, McGregor DG, Schroeder DR, Lanier WL, Shi Q, Hindman BJ et al. IHAST Investigators. Hyperglycemia in patients undergoing cerebral aneurysm surgery: its association with long-term gross neurologic and neuropsychological function. Mayo Clin Proc 2008;83:406-17.
82. Duncan AE, Abd-Elsayed A, Maheshwari A, Xu M, Soltesz E, Koch CG. Role of intraoperative and postoperative blood glucose concentrations in predicting outcomes after cardiac surgery. Anesthesiology 2010;112:860-71.
83. Arabi YM, Dabbagh OC, Tamim HM, Al-Shimemeri AA, Memish ZA, Haddad SH et al. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med 2008;36:3190-7.
84. Bilotta F, Caramia R, Paoloni FP, Delfini R, Rosa G. Safety and efficacy of intensive insulin therapy in critical neurosurgical patients. Anesthesiology 2009;110:611-9.
85. Bilotta F, Caramia R, Cernak I, Paoloni FP, Doronzio A, Cuzzone V et al. Intensive insulin therapy after severe traumatic brain injury: a randomized clinical trial. Neurocrit Care 2008;9:159-66.
86. Yang M, Guo Q, Zhang X, Sun S, Wang Y, Zhao L et al. Intensive insulin therapy on infection rate, days in NICU, in-hospital mortality and neurological outcome in severe traumatic brain injury patients: a randomized controlled trial. Int J Nurs Stud 2009;46:753-8.
87. Coester A, Neumann CR, Schmidt MI. Intensive insulin therapy in severe traumatic brain injury: a randomized trial. J Trauma 2010;68:904-11.
88. Gale SC, Sicoutris C, Reilly PM, Schwab CW, Gracias VH. Poor glycemic control is associated with increased mortality in critically ill trauma patients. Am Surg 2007;73:454-60.
89. Eriksson EA, Christianson DA, Vanderkolk WE, Bonnell BW, Hoogeboom JE, Ott MM. Tight blood glucose control in trauma patients: Who really benefits? J Emerg Trauma Shock 2011;4:359-64.
90. Gibson BR, Galiatsatos P, Rabiee A, Eaton L, Abu-Hamdah R, Christmas C et al. Intensive insulin therapy confers a similar survival benefit in the burn intensive care unit to the surgical intensive care unit. Surgery 2009;146:922-30.
91. Treggiari MM, Karir V, Yanez ND, Weiss NS, Daniel S, Deem SA. Intensive insulin therapy and mortality in critically ill patients. Crit Care 2008;12:R29.
92. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA 2003;290:2041-7.
93. Rady MY, Johnson DJ, Patel BM, Larson JS, Helmers RA. Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes mellitus. Mayo Clin Proc 2005;80:1558-67.
94. Grey NJ, Perdrizet GA. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract 2004;10(Suppl 2):46-52.
95. Reed CC, Stewart RM, Sherman M, Myers JG, Corneille MG, Larson N et al. Intensive insulin protocol improves glucose control and is associated with a reduction in intensive care unit mortality. J Am Coll Surg 2007;204:1048-54.
96. Wahl WL, Taddonio M, Maggio PM, Arbabi S, Hemmila MR. Mean glucose values predict trauma patient mortality. J Trauma 2008;65:42-7.
97. Hemmila MR, Taddonio MA, Arbabi S, Maggio PM, Wahl WL. Intensive insulin therapy is associated with reduced infectious complications in burn patients. Surgery 2008;144:629-35.
98. McAlister FA, Man J, Bistritz L, Amad H, Tandon P. Diabetes and coronary artery bypass surgery: an examination of perioperative glycemic control and outcomes. Diabetes Care 2003;26:1518-24.
99. Hoedemaekers CW, Pickkers P, Netea MG, van Deuren M, Van der Hoeven JG. Intensive insulin therapy does not alter the inflammatory response in patients undergoing coronary artery bypass grafting: a randomized controlled trial [ISRCTN95608630]. Crit Care 2005;9:R790-7.
100. Bilotta F, Spinelli A, Giovannini F, Doronzio A, Delfini R, Rosa G. The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial. J Neurosurg Anesthesiol 2007;19:156-60.
101. Vriesendorp TM, Morélis QJ, Devries JH, Legemate DA, Hoekstra JB. Early post-operative glucose levels are an independent risk factor for infection after peripheral vascular surgery. A retrospective study. Eur J Vasc Endovasc Surg 2004;28:520-5.
102. Ramos M, Khalpey Z, Lipsitz S, Steinberg J, Panizales MT, Zinner M et al. Relationship of perioperative hyperglycemia and postoperative infections in patients who undergo general and vascular surgery. Ann Surg 2008;248:585-91.
103. Bochicchio GV, Salzano L, Joshi M, Bochicchio K, Scalea TM. Admission preoperative glucose is predictive of morbidity and mortality in trauma patients who require immediate operative intervention. Am Surg 2005;71:171-4.
104. Meier R, Béchir M, Ludwig S, Sommerfeld J, Keel M, Steiger P et al. Differential temporal profile of lowered blood glucose levels (3.5 to 6.5 mmol/l versus 5 to 8 mmol/l) in patients with severe traumatic brain injury. Crit Care 2008;12:R98.
105. Subramaniam B, Panzica PJ, Novack V, Mahmood F, Matyal R, Mitchell JD et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology 2009;110:970-7.
106. Thiele RH, Pouratian N, Zuo Z, Scalzo DC, Dobbs HA, Dumont AS et al. Strict glucose control does not affect mortality after aneurismal subarachnoid hemorrhage. Anesthesiology 2009;110:603-10.
107. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003;78:1471-8.
108. Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and shortterm mortality in critically ill patients. Anesthesiology 2006;105:244-52.
109. Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 2009;180:821-7.
110. Qaseem A, Humphrey LL, Chou R, Snow V, Shekelle P; Clinical Guidelines Committee of the American College of Physicians. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2011;154:260-7.
111. Kansagara D, Fu R, Freeman M, Wolf F, Helfand M. Intensive insulin therapy in hospitalized patients: a systematic review. Ann Intern Med 2011;154:268-82.
112. McMullin J, Brozek J, McDonald E, Clarke F, Jaeschke R, Heels-Ansdell D et al. Lowering of glucose in critical care: a randomized pilot trial. J Crit Care 2007;22:112-8.
113. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 2008;300:933-44.
114. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care 2010;33:S11-61.
115. Wilson M, Weinreb J, Hoo GW. Intensive insulin therapy in critical care: a review of 12 protocols. Diabetes Care 2007;30:1005-11.
116. Raucoules-Aime M, Labib Y, Levraut J, Gastaud P, Dolis C, Grimaud D. Use of i.v. insulin in well-controlled noninsulin- dependent diabetics undergoing major surgery. Br J Anesth 1996;76:198-202.
117. Firriolo FJ, Miller CS, Rhodus NL. Perioperative management of diabetic patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103:731-7.
118. Golden SH, Peart-Vigilance C, Kao WH, Brancati FL. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care 1999;22:1408-14.
119. Krinsley JS. Glycemic variability and mortality in critically ill patients: the impact of diabetes. J Diabetes Sci Technol 2009;3:1292-301.
120. Chee F, Fernando T, van Heerden PV. Closed-loop control of blood glucose levels in critically ill patients. Anaesth Intensive Care 2002;30:295-307.
121. Chee F, Fernando T, van Heerden PV. Closed-loop glucose control in critically ill patients using continuous glucose monitoring system (CGMS) in real time. IEEE Trans Inf Technol Biomed 2003;7:43-53.
122. Okabayashi T, Nishimori I, Yamashita K, Sugimoto T, Maeda H, Yatabe T et al. Continuous postoperative blood glucose monitoring and control by artificial pancreas in patients having pancreatic resection: a prospective randomized clinical trial. Arch Surg 2009;144:933-7.
123. Hanazaki K, Maeda H, Okabayashi T. Tight perioperative glycemic control using an artificial endocrine pancreas. Surg Today 2010;40:1-7.
124. Kawahito S, Kitahata H, Kitagawa T, Oshita S. Intensive insulin therapy during cardiovascular surgery. J Med Invest 2010;57:191-204.
125. Trof RJ, Groeneveld AB. Use of synthetic colloids in sepsis: a critical review on efficacy, safety and patient benefits. Minerva Anestesiol 2011;77:1216-23.
126. Schricker T, Lattermann R, Carli F. Intraoperative protein sparing with glucose. J Appl Physiol 2005;99:898-901.
127. Simpson AK, Levy N, Hall GM. Peri-operative IV fluids in diabetic patients - don't forget the salt. Anaesthesia 2008;63:1043-5.
128. Thomas DJ, Alberti KG. Hyperglycemic effects of Hart- mann's solution during surgery in patients with maturity onset diabetes. Br J Anaesth 1978;50:185-8.
129. Hall GM. Management of diabetes during surgery: 30 yr of the Alberti regimen. Anaesthesia 2009;103:789-91.
130. Ljungqvist O. Modulating postoperative insulin resistance by preoperative carbohydrate loading. Best Pract Res Clin Anaesthesiol 2009;23:401-9.
131. Faria MS, de Aguilar-Nascimento JE, Pimenta OS, Alvarenga LC Jr, Dock-Nascimento DB, Slhessarenko N. Preoperative fasting of 2 hours minimizes insulin resistance and organic response to trauma after video-cholecystectomy: a randomized, controlled, clinical trial. World J Surg 2009;33:1158-64.
132. Nygren J, Soop M, Thorell A, Sree Nair K, Ljungqvist O. Preoperative oral carbohydrates and postoperative insulin resistance. Clin Nutr 1999;18:117-20.
133. Nygren J, Thorell A, Ljungqvist O. Preoperative oral carbohydrate nutrition: an update. Curr Opin Clin Nutr Metab Care 2001;4:255-9.
134. Carli F, Galeone M, Gzodzic B, Hong X, Fried GM, Wykes L et al. Effect of laparoscopic colon resection on postoperative glucose utilization and protein sparing: an integrated analysis of glucose and protein metabolism during the fasted and fed States using stable isotopes. Arch Surg 2005;140:593-7.
135. Dungan K, Chapman J, Braithwaite SS, Buse J. Glucose measurement: confounding issues in setting targets for inpatient management. Diabetes Care 2007;30:403-9.
136. De Groene L, Harmsen RE, Binnekade JM, Spronk PE, Schultz MJ. Ex vivo changes in blood glucose levels seldom change blood glucose control algorithm recommendations. Minerva Anestesiol 2010;76:1018-23.